FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Carvykti Approved for Expanded Myeloma Use

[ Price : $8.95]

FDA approves a supplemental BLA submitted by Janssen for Carvykti (ciltacabtagene autoleucel) to treat adults with relapsed or ref...

FDA 2nd Complete Response on Parkinsons Drug

[ Price : $8.95]

FDA sends Supernus Pharmaceuticals a second complete response letter on its NDA resubmission for the companys apomorphine infusion...

Nominations Sought for Patient Engagement Panel

[ Price : $8.95]

Federal Register notice: FDA requests nominations for voting members, excluding consumer and industry representatives, to serve on...

Meeting on User Fee Program Financials

[ Price : $8.95]

Federal Register notice: FDA announces a 6/6 public meeting entitled Financial Transparency and Efficiency of the Prescription Dru...

24 Drugs Not Withdrawn Due to Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that 24 listed drug products were not withdrawn from sale for reasons of safety or effecti...

De Novo for Antibacterial Coated Implants

[ Price : $8.95]

FDA grants Onkos Surgical a de novo marketing authorization for its novel antibacterial coated implants.

Shuffert Debarred for 5 Years

[ Price : $8.95]

Federal Register notice: FDA issues an order to debar for five years Robert Lance Shuffert from importing or offering for import a...

Abecma Expanded Approval for Multiple Myeloma

[ Price : $8.95]

FDA approves a Bristol Myers Squibb and 2Seventy Bio supplemental BLA for Abecma (idecabtagene vicleucel; ide-cel) for treating ce...

Honeywell Recalls Eyewash Cartridge

[ Price : $8.95]

Honeywell Safety Products recalls its Fendall 2000 Non-Sterile Eyewash Cartridge for the Fendall 2000 Eyewash Station due to GMP c...

Accelerated Approval for Enhertu in Solid Tumors

[ Price : $8.95]

FDA grants Daiichi Sankyo an accelerated approval for Enhertu (fam-trastuzumab deruxtecan-nxki) for treating certain adult patient...